Syamal K. Bhattacharya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Syamal K. Bhattacharya has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Amandeep Bajwa
The University of Tennessee Health Science Center
1 shared publication - Babatunde O. Komolafe
University of Tennessee Health Science Center
1 shared publication - Canan Kuscu
Department of Surgery, Transplant Research Institute, James D. Eason Transplant Institute, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN 38103, USA
1 shared publication - Cem Kuscu
Department of Surgery, Transplant Research Institute, James D. Eason Transplant Institute, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN 38103, USA
1 shared publication - Christopher Castelow
Department of Surgery, Transplant Research Institute, James D. Eason Transplant Institute, College of Medicine, The University of Tennessee Health Science Center, Memphis, TN 38103, USA
1 shared publication - Disha S. Patel
School of Interdisciplinary Studies and Global Education, Belmont University, Nashville, TN 37212, USA
1 shared publication
Latest Publications
- Open Access
- 27 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (21) , 12993
Mitochondrial Role in Oncogenesis and Potential Chemotherapeutic Strategy of Mitochondrial Infusion in Breast Cancer
Triple negative breast cancer (TNBC) is one of the most aggressive cancers diagnosed amongst women with a high rate of treatment failure and a poor prognosis. Mitochondria have been found to be key players in oncogenesis and tumor progression by mechanisms such as altered metabolism, reactive oxygen species (ROS) production and evasion of apoptosis. Therefore, mitochondrial infusion is an area of interest for cancer treatment. Studies in vitro and in vivo demonstrate mitochondrial-mediated reduction in glycolysis, enhancement of oxidative phosphorylation (OXPHOS), reduction in proliferation, and an enhancement of apoptosis as effective anti-tumor therapies. This review focuses on mitochondrial dysregulation and infusion in malignancies, such as TNBC.
- 27 October 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (21) , 12993
Open AccessMitochondrial Role in Oncogenesis and Potential Chemotherapeutic Strategy of Mitochondrial Infusion in Breast Cancer
Triple negative breast cancer (TNBC) is one of the most aggressive cancers diagnosed amongst women with a high rate of treatment failure and a poor prognosis. Mitochondria have been found to be key players in oncogenesis and tumor progression by mechanisms such as altered metabolism, reactive oxygen species (ROS) production and evasion of apoptosis. Therefore, mitochondrial infusion is an area of interest for cancer treatment. Studies in vitro and in vivo demonstrate mitochondrial-mediated reduction in glycolysis, enhancement of oxidative phosphorylation (OXPHOS), reduction in proliferation, and an enhancement of apoptosis as effective anti-tumor therapies. This review focuses on mitochondrial dysregulation and infusion in malignancies, such as TNBC.
- 9 August 2012
- Published by Springer Nature
- p. 241-254
Magnesium and Its Interdependency with Other Cations in Acute and Chronic Stressor States
- 9 August 2012
- Published by Springer Nature
- p. 241-254
Magnesium and Its Interdependency with Other Cations in Acute and Chronic Stressor States